Clinical significance of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia

Leuk Lymphoma. 2007 May;48(5):849-50. doi: 10.1080/10428190701305957.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies / chemistry
  • Antibody Formation
  • Antineoplastic Agents / pharmacology
  • Asparaginase / antagonists & inhibitors*
  • Asparaginase / immunology*
  • Asparaginase / metabolism
  • Child
  • Clinical Trials as Topic
  • Disease-Free Survival
  • Humans
  • Immunotherapy / methods*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Treatment Outcome

Substances

  • Antibodies
  • Antineoplastic Agents
  • Asparaginase